Modulation of cyclophosphamide-induced cellular toxicity by diphenylmethyl selenocyanate in vivo, an Enzymatic study

Journal of Cancer Molecules

Volumn 4, Issue 6, 2009, Pages 183-189

  Chakraborty, Pramita ^a   Hossain Sk, Ugir ^a   Jayanta, Nabendu Murmu ^a   Das, Kumar ^a   Pal, Smarajit ^b   Bhattacharya, Sudin ^a  

^a Chittaranajan National Cancer Institute   (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Antioxidant; Cyclophosphamide; Diphenylmethyl selenocyanate; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CYCLOPHOSPHAMIDE; DIPHENYLMETHYL SELENOCYANATE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN; NITRITE; SELENIUM DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; IN VIVO STUDY; LIPID PEROXIDATION; LIVER; LUNG PARENCHYMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE;

EID: 67649239089     PISSN: 18160735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Baumann F, Preiss R. Cyclophosphamide and related anticancer drugs. J Chromatogr B: Biomed Sci Appl 764: 173-192, 2001.
2. Fleming RE. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 17: 1465-1545, 1997.
3. Hales BE. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein. Cancer Res 42: 3016-3021, 1982.
4. Bukowski R. The need for cytoprotection. Eur J Cancer 32A: S2-S4, 1999.
5. Fraiser LH, Kanekel S, Kehrer JP. Cyclophosphamide toxicity; characterizing and avoiding the problem. Drug 42: 781-795, 1991.
6. Das UB, Mallick M, Debnath JM, Ghosh D. Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorder in male rats. Asian J Androl 4: 201-207, 2002.
7. Ghosh D, Das UB, Ghosh S, Mallick M, Debnath J. Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress. Drug Chem Toxicol 25: 281-292, 2002.
8. Haque R, Bin-Hafeez, Ahmad I, Parvez S, Pandey S, Raisuddin S. Protective effect of Emblica officinalis Gaertn in cyclophosphamide treated mice. Hum Exp Biol 20: 643-650, 2001.
9. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23: 209-240, 1997.
10. Barber DA, Harris SR. Oxygen free radicals and antioxidants: a review. Am pharm 34: 26-35, 1994.
11. Jose LQ, Jesus RH, Maurizio B, Jose M, Ramirez-Tortosa CM. Antioxidant nutrients and adriamycin toxicity. Toxicol 180: 79-95, 2002.
12. Matsumoto K, Inagaki T, Hirunuma R, Enomoto S, Endo S. Contents and uptake rates of Mn, Fe, Co, Zn, and Se in Se-deficient rat liver cell fractions. Anal Sci 17: 587-591, 2001.
13. Sugie S, Tanaka T, El-Bayoumy K. Chemoprevention of carcinogenesis by organoselenium compounds. J Health Sci 46: 422-425, 2000.
14. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 128: 1845-1854, 1998.
15. Narajji C, Karvekar MD, Das AK. Biological importance of organoselenium compounds. Ind J Pharm Sci 69: 344-351, 2007.
16. Muller A, Cadenas E, Graf P, Sies H. A novel biologically active seleno-organic compound-I. Biochem Pharmacol 33: 3235-3239, 1984.
17. Das RK, Bhattacharya S. Inhibition of DMBA-croton oil two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate through modulation of cutaneous oxidative stress and inhibition of nitric oxide production. Asian Pacific J Cancer Prev 5: 151-158, 2004.
18. Das RK, Das S, Bhattacharya S. Protective effect of diphenylmethyl selenocyanate against carbon tetrachloride induced hepatotoxicity in vivo. J Environ Path Toxicol Oncol 23: 287-296, 2004.
19. Das RK, Sk UH, Bhattacharya S. Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation. Cancer Lett 230: 90-101, 2005.
20. Pederson CT. Preparation of some 4-substituted selenosemicarbazides. Acta Chemica Scandinavica 17: 1459-1461, 1963.
21. Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thioberbituric acid reaction. Annal Biochem 95: 351-358, 1979.
22. Sedlack J, Lindsay RN. Estimation of total protein bound and non-protein sulphydryl groups in tissue with ellman reagent. Annal Biochem 25: 192-205, 1968.
23. Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferase, the first enzymatic step in marcapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
24. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169, 1967.
25. Luck H. A spectrophotometric method for estimation of catalase. In: Bergmeyer HV, ed. Methods of enzymatic analysis. New York: Academy Press 1963: 886-888.
26. Marklund S, Marklund G. Involvement of the superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474, 1974.
27. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemoprotein). J Biol Chem 244: 6049-6055, 1969.
28. Green LC, Luzuriaga RKD, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78: 7764-7768, 1981.
29. Wintrobe MM. Clinical hematology, 7th ed. Philadelphia: Lea & Febiger 1975: 114-115.
30. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 193: 265-276, 1951.
31. Patel JM, Block ER. Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lungs. Exp Lung Res 8: 153-165, 1985.
32. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142: 79-87, 1995.
33. Kaya H, Oral B, Ozguner F, Tahan V, Babar Y, Delibas N. The effect of melatonin application on lipid peroxidation during cyclophosphamide therapy in female rats. Zentralbl Gynakol 121: 499-502, 1999.
34. Lear L, Nation RL, Stupans I. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem Pharmacol 44: 747-753, 1992.
35. Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res 16: 407-411, 1997.
36. Premkumar K, Pachiappan A, Abraham SK, Santhiya ST, Gopinath PM, Ramesh A. Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 72: 906-911, 2001.
37. Halliwell B, Gutteridge JM. Free radicals in biology and medicine, 2nd ed. Oxford: Clarendon Press, 1989.
38. Haque R, Bin-Hafeez B, Parvez S, Pandey S, Sayeed I, Ali M, Raisuddin S. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 22: 473-480, 2003.
39. Patel JM. Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicol 45: 79-91, 1987.
40. Selvakumar E, Prahalathan C, Mythili Y, Varalakshmi P. Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-alpha-lipoic-acid. Mol Cell Biochem 272: 179-185, 2005.
41. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142: 79-87, 1995.
42. Adams JD, Klaidman LK. Acrolein induced oxygen radical formation. Free Radic Biol Med 15: 187-193, 1993.
43. Uchida K. Current status of acrolein as a lipid product. Trends Cardiovasc Med 9: 109-113, 1999.
44. Ali-Osman F. Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione. Cancer Res 49: 5258-5261, 1989.
45. McDiarmid MA, Iype PT, Koldner K, Jacobnson KD, Strickland PT. Evidence for acrolein-modified DNA in peripheral blood leucocytes of cancer patients treated with cyclophosphamide. Mutat Res 248: 93-99, 1991.
46. Touliatos JS, Neitzel L, Whitworth C, Rybak LP, Malafa M. Effect of cisplatin on the expression of glutathione-S-transferase in the cochlea of the rat. Eur Arch Otorhinolaryngol 25: 6-9, 2000.
47. Weiming XU, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 12: 311-320, 2002.
48. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-507, 1991.
49. Vander VA, Smith D, O'Neill CA, Kaur H, Darley-Usmar V, Cross CE, Halliwell B. Interaction of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 303: 295-301, 1994.
50. Tamir S, Tannenbaum SR. The role of nitric oxide (NO.) in the carcinogenic process. Biochem Biophys Acta 1288: F31-F36, 1996.
51. Kumar G, Banu SG, Kannan V, Pandian RM. Antihepatotoxic effect of β-carotene on paracetamol induced hepatic damage in rats. Ind J Exp Biol 43: 351-355, 2005.
52. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91: 1616-1634, 1999.